NASDAQ: TDAC
Translational Development Acquisition Corp Stock Ownership - Who owns Translational Development Acquisition?

Insider buying vs selling

Have Translational Development Acquisition Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TDAC insiders and whales buy or sell their stock.

TDAC Shareholders

What type of owners hold Translational Development Acquisition Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aqr Arbitrage LLC6.78%1,485,000$15.07MInstitution
Magnetar Financial LLC5.93%1,300,000$13.20MInstitution
Healthcare Of Ontario Pension Plan Trust Fund4.11%900,000$9.14MInstitution
Polar Asset Management Partners Inc3.65%800,000$8.12MInstitution
Lmr Partners LLP3.65%800,000$8.12MInstitution
K2 Principal Fund LP3.08%674,997$6.85MInstitution
First Trust Capital Management LP2.97%650,000$6.60MInstitution
Hudson Bay Capital Management LP2.97%650,000$6.60MInstitution
Tenor Capital Management Co LP2.90%635,399$6.45MInstitution
Crossingbridge Advisors LLC2.74%600,000$6.09MInstitution

1 of 3

TDAC vs Shell Company Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TDAC68.21%0.00%
MACI68.88%0.00%
DYNX69.16%0.00%
SVCC0.00%5.07%
NTWO68.49%2.01%Net Buying

Translational Development Acquisition Stock Ownership FAQ

Who owns Translational Development Acquisition?

Translational Development Acquisition (NASDAQ: TDAC) is owned by 68.21% institutional shareholders, 0.00% Translational Development Acquisition insiders, and 31.79% retail investors. Aqr Arbitrage LLC is the largest individual Translational Development Acquisition shareholder, owning 1.49M shares representing 6.78% of the company. Aqr Arbitrage LLC's Translational Development Acquisition shares are currently valued at $15.13M.

If you're new to stock investing, here's how to buy Translational Development Acquisition stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.